Harm Van Tinteren

Harm Van Tinteren

Netherlands Cancer Institute - Amsterdam / Netherlands
Others
AD Scientific Index ID: 4963196
Nederlands Kanker Instituut
person_outline Harm Van Tinteren's MOST POPULAR ARTICLES
1-) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis … Journal of clinical oncology 21 (20), 3737-3743, 2003
2-) Hyperthermic intraperitoneal chemotherapy in ovarian cancer New England Journal of Medicine 378 (3), 230-240, 2018
3-) AACR Project GENIE: powering precision medicine through an international consortium Cancer discovery 7 (8), 818-831, 2017
4-) 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of … Annals of surgical oncology 15, 2426-2432, 2008
5-) 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of …VJ Verwaal, S Bruin, H Boot, G Van Slooten, H Van TinterenAnnals of surgical oncology 15, 2426-2432, 200812282008